Evidence for an alternatively spliced MITF exon 2 variant.
Cancer Drug Mechanisms Group, Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Jacinta L
JL
Simmons
Cancer Drug Mechanisms Group, Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Carly J
CJ
Pierce
Cancer Drug Mechanisms Group, Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Electronic address: Glen.Boyle@qimrberghofer.edu.au.
Glen M
GM
Boyle
D017398:Alternative Splicing; D000595:Amino Acid Sequence; D045744:Cell Line, Tumor; D005091:Exons; D005786:Gene Expression Regulation; D014644:Genetic Variation; D006801:Humans; D008544:Melanocytes / Q000166:cytology / Q000378:metabolism; D008545:Melanoma / Q000378:metabolism; D051739:Microphthalmia-Associated Transcription Factor / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation; D011401:Promoter Regions, Genetic; D017433:Protein Structure, Secondary; D012333:RNA, Messenger / Q000378:metabolism; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000378:metabolism
D051739:Microphthalmia-Associated Transcription Factor; D012333:RNA, Messenger